Results 21 to 30 of about 298,536 (314)

Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of Echocardiography. [PDF]

, 2018
Pulmonary hypertension is defined as a mean arterial pressure of ≥25 mmHg as confirmed on right heart catheterisation. Traditionally, the pulmonary arterial systolic pressure has been estimated on echo by utilising the simplified Bernoulli equation from ...
Augustine, DX, Bhattacharyya, S, British Society of Echocardiography Education Committee,, Coates-Bradshaw, LD, Coghlan, G, Fox, K, Grapsa, J, Harkness, A, Howard, LS, Kaye, N, Mathew, T, Nihoyannopoulos, P, Oxborough, D, Rana, BS, Ring, L, Robinson, S, Sandoval, J, Sharma, V, Siva, A, Steeds, RP, Willis, J   +20 more
core   +3 more sources

Incident pulmonary arterial hypertension associated with Bosutinib

Pulmonary Circulation, 2020
Pulmonary arterial hypertension is associated with tyrosine kinase inhibitors used in the treatment of chronic myeloid leukemia. Dasatinib is a known cause of drug-induced pulmonary arterial hypertension.
Shaun Yo, John Thenganatt, Jeffrey Lipton, John Granton   +3 more
doaj   +1 more source

Impact of the updated hemodynamic definitions on diagnosis rates of pulmonary hypertension

Pulmonary Circulation, 2020
We evaluated whether updated pulmonary hypertension definitive criteria proposed in sixth World Symposium on Pulmonary Hypertension had an impact on diagnosis of overall pulmonary hypertension and pre-capillary and combined pre- and post-capillary ...
Seda Tanyeri, Ozgur Y. Akbal, Berhan Keskin, Aykun Hakgor, Ali Karagoz, Hacer Ceren Tokgoz, Cem Dogan, Zubeyde Bayram, Seyhmus Kulahcioglu, Emrah Erdogan, Ismail Balaban, Dogancan Ceneli, Rezzan Deniz Acar, Ibrahim H. Tanboga, Nihal Ozdemir, Cihangir Kaymaz   +15 more
doaj   +1 more source

Transcription factors and potential therapeutic targets for pulmonary hypertension

Frontiers in Cell and Developmental Biology, 2023
Pulmonary hypertension (PH) is a refractory and fatal disease characterized by excessive pulmonary arterial cell remodeling. Uncontrolled proliferation and hypertrophy of pulmonary arterial smooth muscle cells (PASMCs), dysfunction of pulmonary arterial ...
Liu Yang, Naifu Wan, Fanpeng Gong, Xianfeng Wang, Lei Feng, Guizhu Liu   +5 more
doaj   +1 more source

Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study [PDF]

, 2017
BackgroundIdiopathic and heritable pulmonary arterial hypertension form a rare but molecularly heterogeneous disease group. We aimed to measure and validate differences in plasma concentrations of proteins that are associated with survival in patients ...
Abdul-Salam, Ahmad, Benza, Benza, D'Alonzo, Delafontaine, Galie, Ganz, Geraci, Gold, Hansmann, Humbert, Johnson, Kundu, Kwapiszewska, Lavoie, Lepetit, Machado, McGoon, Nickel, Pencina, Rhodes, Rhodes, Schermuly, Shah, Soon, Vander, Walport, Weinberg, Weinberg   +29 more
core   +1 more source

Quantification of Pulmonary Arterial Wall Distensibility Using Parameters Extracted from Volumetric Micro-CT Images [PDF]

, 1999
Stiffening, or loss of distensibility, of arterial vessel walls is among the manifestations of a number of vascular diseases including pulmonary arterial hypertension.
Dawson, Christopher A, Johnson, Roger H., Karau, Kelly Lynn, Molthen, Robert C.   +3 more
core   +2 more sources

Clinical heterogeneity of Pulmonary Arterial Hypertension associated with variants in TBX4.

PLoS ONE, 2020
BACKGROUND:The knowledge of hereditary predisposition has changed our understanding of Pulmonary Arterial Hypertension. Genetic testing has been widely extended and the application of Pulmonary Arterial Hypertension specific gene panels has allowed its ...
Ignacio Hernandez-Gonzalez, Jair Tenorio, Julian Palomino-Doza, Amaya Martinez Meñaca, Rafael Morales Ruiz, Mauro Lago-Docampo, María Valverde Gomez, Javier Gomez Roman, Ana Belén Enguita Valls, Carmen Perez-Olivares, Diana Valverde, Joan Gil Carbonell, Elvira Garrido-Lestache Rodríguez-Monte, Maria Jesus Del Cerro, Pablo Lapunzina, Pilar Escribano-Subias   +15 more
doaj   +1 more source

Role of prostacyclin in pulmonary hypertension [PDF]

, 2014
Date of Acceptance: 11/12/2014 This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY-4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is ...
Ali FY, Butrous G, Chester AH, Geiger LE, Newsholme SJ, Nguyen H, Ruan CH, Smith WL, Whittaker N   +8 more
core   +3 more sources

Anticoagulation in pulmonary arterial hypertension: a decision analysis

Pulmonary Circulation, 2019
Systemic anticoagulation may be beneficial in pulmonary arterial hypertension, but there is no randomized clinical trial data to guide therapeutic decision making, and current guidelines do not account for patient preferences or quality of life. Decision
Arun Jose, Mark H. Eckman, Jean M. Elwing   +2 more
doaj   +1 more source

Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension

Pulmonary Circulation, 2019
Pulmonary arterial hypertension is a severe disease for which diagnosis often is delayed. Matrix metalloproteinases have been suggested to play a role in vascular remodeling and pulmonary hypertension development. Our aim was therefore to investigate the
Mattias Arvidsson, Abdulla Ahmed, Habib Bouzina, Göran Rådegran   +3 more
doaj   +1 more source